Showing results (231-240 of 325) with videos related to
Sort By:
Pageof 33
Chemical & Pharmaceutical Bulletin|December 3, 2023
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond ReplacementKohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, et al.Journal of Medicinal Chemistry|May 29, 2009
Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studiesArun K Ghosh, Sofiya Leshchenko-Yashchuk, David D Anderson, et al.Chemmedchem|September 25, 2019
Potent HIV-1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein-Ligand X-ray Structural StudiesArun K Ghosh, Zilei Xia, Satish Kovela, et al.Scientific Reports|March 11, 2021
Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasmaKenji Maeda, Nobuyo Higashi-Kuwata, Noriko Kinoshita, et al.Bioorganic & Medicinal Chemistry Letters|November 23, 2006
Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metaboliteRena Nishizawa, Toshihiko Nishiyama, Katsuya Hisaichi, et al.Antimicrobial Agents and Chemotherapy|January 24, 2019
CMCdG, a Novel Nucleoside Analog with Favorable Safety Features, Exerts Potent Activity against Wild-Type and Entecavir-Resistant Hepatitis B VirusNobuyo Higashi-Kuwata, Sanae Hayashi, Debananda Das, et al.Antiviral Research|February 22, 2020
7-Deaza-7-fluoro modification confers on 4'-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safetySanae Hayashi, Nobuyo Higashi-Kuwata, Debananda Das, et al.Organic & Biomolecular Chemistry|October 10, 2008
Potent HIV-1 protease inhibitors incorporating meso-bicyclic urethanes as P2-ligands: structure-based design, synthesis, biological evaluation and protein-ligand X-ray studiesArun K Ghosh, Sandra Gemma, Jun Takayama, et al.Bioorganic & Medicinal Chemistry Letters|June 23, 2015
Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligandsArun K Ghosh, Jun Takayama, Luke A Kassekert, et al.Frontiers in Microbiology|April 5, 2021
A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC ActivatorsKouki Matsuda, Takuya Kobayakawa, Ryusho Kariya, et al.Pageof 33